A Phase 2, Open-label, Multicenter, Dose-Escalation and Expansion Study of Venetoclax in Combination with Pomalidomide and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
Administered By
Awarded By
Contributors
- Gasparetto, Cristina Principal Investigator
Start/End
- October 25, 2018 - October 31, 2023